Or Eisenberg has bought stock on 2 days since Mar 2021

Or Eisenberg is a certified public accountant and the Chief Financial Officer of NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company focused on developing treatments for neurodegenerative diseases.( In this role, he oversees the company’s global financial operations and has been instrumental in managing its capital markets activities, including equity compensation programs and insider-led financings, such as a 2026 PIPE financing in which he personally participated alongside other company insiders.( He has worked with NeuroSense for several years, initially from its Herzliya, Israel office before relocating to the United States, where he continues to lead the company’s finance function.(

Eisenberg has broad experience with public companies in both Israel and the United States, spanning accounting, financial management, and executive leadership in the biotech and investment sectors.( Prior to joining NeuroSense, he held senior roles including CFO and acting CEO of Wize Pharma Inc., served as controller of the Katzir Fund Group, and acted as external CFO for several companies listed on the Tel Aviv Stock Exchange.( He began his career as an accountant at Ernst & Young and holds a B.A. in Economics and Accounting from the University of Haifa, along with CPA certification.(

Written by Perplexity from public sources.